NCT00803816View on ClinicalTrials.gov

Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2010

Conditions
Uveitis
Interventions
DRUG

everolimus

everolimus 1.0 - 2.5mg oral daily dosage

Trial Locations (1)

48145

Department of Ophthalmology at St. Franziskus Hospital, Münster

All Listed Sponsors
lead

Carsten Heinz

OTHER

NCT00803816 - Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A | Biotech Hunter | Biotech Hunter